Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib

• Matthias Scheffler ,

  Contributed equally to this work with: Matthias Scheffler, Thomas Zander

  Affiliations Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany, Center for Integrated Oncology Köln Bonn, Cologne, Germany

  ⨯
• Thomas Zander ,

  Contributed equally to this work with: Matthias Scheffler, Thomas Zander

  Affiliations Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany, Center for Integrated Oncology Köln Bonn, Cologne, Germany

  ⨯
• Lucia Nogova,

  Affiliations Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany, Center for Integrated Oncology Köln Bonn, Cologne, Germany

  ⨯
• Carsten Kobe,

  Affiliation Clinic for Nuclear Medicine, University Hospital of Cologne, Cologne, Germany

  ⨯
• Deniz Kahraman,

  Affiliation Clinic for Nuclear Medicine, University Hospital of Cologne, Cologne, Germany

  ⨯
• Markus Dietlein,

  Affiliation Clinic for Nuclear Medicine, University Hospital of Cologne, Cologne, Germany

  ⨯
• Irini Papachristou,

  Affiliations Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany, Center for Integrated Oncology Köln Bonn, Cologne, Germany

  ⨯
• Lukas Heukamp,

  Affiliations Center for Integrated Oncology Köln Bonn, Cologne, Germany, Institute of Pathology, University Hospital Cologne, Cologne, Germany

  ⨯
• Reinhard Büttner,

  Affiliations Center for Integrated Oncology Köln Bonn, Cologne, Germany, Institute of Pathology, University Hospital Cologne, Cologne, Germany

  ⨯
• Ron Boellaard,

  Affiliation Department of Nuclear Medicine and PET Research, VU University Medical Center Amsterdam, Amsterdam, The Netherlands

  ⨯
• Adriaan A. Lammertsma,

  Affiliation Department of Nuclear Medicine and PET Research, VU University Medical Center Amsterdam, Amsterdam, The Netherlands

  ⨯
• Silvia Querings,

  Affiliation Max-Planck Institute for Neurological Research, Cologne, Germany

  ⨯
• Erich Stoelben,

  Affiliation Lung Clinic Merheim, Hospital of Cologne, Cologne, Germany

  ⨯
• Walburga Engel-Riedel,

  Affiliation Lung Clinic Merheim, Hospital of Cologne, Cologne, Germany

  ⨯
• Bernd Neumaier,

  Affiliation Max-Planck Institute for Neurological Research, Cologne, Germany

  ⨯
•  [ ... ],
• Jürgen Wolf

  * E-mail: juergen.wolf@uk-koeln.de

  Affiliations Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany, Center for Integrated Oncology Köln Bonn, Cologne, Germany

  ⨯
• [ view all ]
• [ view less ]